Clinical characteristics and treatment of “cytopenia phenotype” in Behçet syndrome: A Retrospective Cohort Study using a large data set from a referral center in China

Yan Shen,Lin Shen,Dan Luo,Hai-fen Ma,Lei-lei Jian,Jian-fei Cai,Jun Zou,Jian-long Guan
DOI: https://doi.org/10.21203/rs.3.rs-1748211/v1
2022-01-01
Abstract:Abstract Objectives: This study aimed to describe the characteristics, treatment, and outcome of hematological involvement and assess possible association to define a “cytopenia phenotype” in BS patients. Methods: This was a retrospective study of BS patients in Shanghai Behçet syndrome database who were diagnosed with hematological involvement between October 2012 and December 2021. Results: A total of 40 BS patients with cytopenia were included (2.1%, 40/1950), the median follow-up duration was 35 (3-92) months. They presented high rate of trisomy 8 in the bone marrow (n=33, 82.5%). BS patients with cytopenia were more likely to be older age, female and have fewer skin lesions. Gastrointestinal (GI) ulceration, fever and high level of erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) were more frequent in BS patients with cytopenia. Ulcers in the ileocecal, small intestine and colon region and symptoms such as abdominal pain, weight loss and fever were more frequently seen in intestinal BS patients with cytopenia. All these cytopenia BS patients received standard guideline treatment regimens. In the follow-up, eight BS patients with cytopenia (8/40, 20.0%) died, 9 (22.5%) had not improved. As compared to alive BS patients, died BS patients were more likely to be older age and have high level of ESR.Conclusions:BS patients with cytopenia displayed a high rate of somatic mutations trisomy 8, GI involvement and high risk of death. Management of cytopenia was highly heterogeneous and many of the current treatment options are highly variable and suboptimal.
What problem does this paper attempt to address?